×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Oragenics Inc. to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference
The Globe and Mail
Oragenics, Inc. (NYSE American: OGEN), a biopharmaceutical company dedicated to the development and commercialization of a vaccine candidate to combat the...
4 hours ago
Oragenics, Inc. Announces $6.5 Million Registered Direct Offering
The Globe and Mail
Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a company focused on the creation of the Terra CoV-2 vaccine candidate...
7 hours ago
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
markets.businessinsider.com
SARASOTA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneer in developing innovative intranasal...
4 days ago
Oragenics, Inc. Files 10K and Provides Company Update
Business Wire
Oragenics, Inc. (the “Company”) (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment...
1 month ago
Oragenics Inc Reports SEC Filing Update - TipRanks.com
Tipranks
Oragenics Inc (OGEN) has released an update. Oragenics, Inc., a company registered in Florida, has submitted a Form 8-K report with the SEC,...
4 days ago
Oragenics partners with Avance Clinical for Phase 2 concussion study (NYSE:OGEN)
Seeking Alpha
Oragenics (OGEN) has partnered with Avance Clinical to conduct a Phase 2 trial for its drug ONP-002 in the treatment of mild traumatic brain...
4 days ago
StockNews.com Begins Coverage on Oragenics (NYSE:OGEN)
Defense World
StockNews.com started coverage on shares of Oragenics (NYSE:OGEN – Free Report) in a report issued on Thursday. The brokerage issued a sell...
5 days ago
Oragenics acquires neurological assets from Odyssey Health
Pharmaceutical Technology
Oragenics acquires neurological assets from Odyssey Health. The move includes the acquisition of a concussion product, ONP-002, and a nasal...
4 months ago
Why Is Oragenics (OGEN) Stock Down 45% Today?
InvestorPlace
How This Affects OGEN Stock. A public stock offering increases the total number of OGEN shares on the market. That means it also dilutes the...
2 months ago
Sarasota biotech company noncompliant with NYSE listing standards
Business Observer
Oragenics was notified by the New York Stock Exchange American that its stockholders' equity total was below a required threshold.
3 weeks ago